TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nutritional Supplementation for Extending Time Between Recurrent Urinary Tract Infections in Women: a Randomized Double Blind Cross-over Trial
Brief Summary: The study will test the ability of specially formulated nutritional supplement capsules to extend the time between recurrent urinary tract infections in women. This objective will be completed by enrolling women who have suffered from 3-4 uncomplicated UTIs in the past 12 months into a double blind placebo controlled cross-over trial. Cross-over and study completion are triggered by the next two UTI recurrences. The goal of the study is for the supplement to extend the time to the next UTI for study participants as compared to placebo.


Options:
A: Arm Label: Cranberry capsule; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cranberry capsules | Arm Label: Placebo capsule; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Cranberry capsules | Intervention Type: DIETARY_SUPPLEMENT; Name: Cranberry capsules; Assigned to Arm(s): Cranberry capsule, Placebo capsule
B: Intervention Type: DRUG; Name: Cranberry juice; Assigned to Arm(s): N/A
C: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Dietary Supplement: WelTract | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: WelTract; Assigned to Arm(s): Treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Control
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Cranberry; Type: EXPERIMENTAL; Interventions: Drug: Cranberry | Intervention Type: DRUG; Name: Cranberry; Assigned to Arm(s): Cranberry | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nutritional Supplementation for Extending Time Between Recurrent Urinary Tract Infections in Women: a Randomized Double Blind Cross-over Trial
Brief Summary: The study will test the ability of specially formulated nutritional supplement capsules to extend the time between recurrent urinary tract infections in women. This objective will be completed by enrolling women who have suffered from 3-4 uncomplicated UTIs in the past 12 months into a double blind placebo controlled cross-over trial. Cross-over and study completion are triggered by the next two UTI recurrences. The goal of the study is for the supplement to extend the time to the next UTI for study participants as compared to placebo.


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Dietary Supplement: WelTract | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: WelTract; Assigned to Arm(s): Treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Control
B: Arm Label: mannose; Type: EXPERIMENTAL; Interventions: Drug: Mannose | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Lactose | Intervention Type: DRUG; Name: Mannose; Assigned to Arm(s): mannose | Intervention Type: DRUG; Name: Lactose; Assigned to Arm(s): placebo
C: Arm Label: D Mannose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: D Mannose, Drug: trimethoprim/sulfamethoxazole | Arm Label: trimethoprim/sulfamethoxazole; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: D Mannose, Drug: trimethoprim/sulfamethoxazole | Intervention Type: DIETARY_SUPPLEMENT; Name: D Mannose; Assigned to Arm(s): D Mannose, trimethoprim/sulfamethoxazole | Intervention Type: DRUG; Name: trimethoprim/sulfamethoxazole; Assigned to Arm(s): D Mannose, trimethoprim/sulfamethoxazole
D: Arm Label: Methenamine augmentation; Type: EXPERIMENTAL; Interventions: Drug: Methenamine Hippurate 1000 MG, Drug: Vaginal estrogen, Dietary Supplement: D-mannose | Arm Label: No methenamine augmentation; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vaginal estrogen, Dietary Supplement: D-mannose | Intervention Type: DRUG; Name: Methenamine Hippurate 1000 MG; Assigned to Arm(s): Methenamine augmentation | Intervention Type: DRUG; Name: Vaginal estrogen; Assigned to Arm(s): Methenamine augmentation, No methenamine augmentation | Intervention Type: DIETARY_SUPPLEMENT; Name: D-mannose; Assigned to Arm(s): Methenamine augmentation, No methenamine augmentation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Single-center, Open Study Evaluating Efficacy and Safety of XLCART001（CD-19） Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects
Brief Summary: The trial is a single arm, single-center, non-randomized clinical trial which is designed to evaluate the efficacy and safety of XLCART001 in treatment of relapsed/refractory/high-risk B-cell malignancy subjects


Options:
A: Arm Label: JWCAR029; Type: EXPERIMENTAL; Interventions: Biological: JWCAR029 | Intervention Type: BIOLOGICAL; Name: JWCAR029; Assigned to Arm(s): JWCAR029
B: Arm Label: Administration of JCAR017; Type: EXPERIMENTAL; Interventions: Drug: JCAR017 | Intervention Type: DRUG; Name: JCAR017; Assigned to Arm(s): Administration of JCAR017
C: Arm Label: Tisagenlecleucel; Type: EXPERIMENTAL; Interventions: Biological: Tisagenlecleucel, Drug: Lymphodepleting chemotherapy | Intervention Type: BIOLOGICAL; Name: Tisagenlecleucel; Assigned to Arm(s): Tisagenlecleucel | Intervention Type: DRUG; Name: Lymphodepleting chemotherapy; Assigned to Arm(s): Tisagenlecleucel
D: Intervention Type: BIOLOGICAL; Name: chimeric antigen receptor T cells; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Testing the Efficacy of the Teachable Moment Brief Intervention for Suicide Attempt Survivors in an Inpatient Setting: Effects on Psychosocial and Experimental Pain Outcomes
Brief Summary: This study is looking at the helpfulness of a brief treatment targeting suicidality (Teachable Moment Brief Intervention \[TMBI\]) and experimental pain responses in an inpatient population as well as collecting comparison data from the community.


Options:
A: Arm Label: Peer Mentorship intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer mentorship | Arm Label: Enhanced Usual Care (EUC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Peer mentorship; Assigned to Arm(s): Peer Mentorship intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care (EUC)
B: Arm Label: 1; Type: OTHER; Interventions: Drug: Naltrexone | Arm Label: 2; Type: OTHER; Interventions: Drug: Naltrexone | Arm Label: 3; Type: OTHER; Interventions: Drug: Naltrexone | Arm Label: 4; Type: OTHER; Interventions: Drug: Naltrexone | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): 1, 2, 3, 4
C: Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention (TMBI) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Control Group (CCG); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention (TMBI); Assigned to Arm(s): Teachable Moment Brief Intervention
D: Arm Label: App-Condition; Type: EXPERIMENTAL; Interventions: Device: Monsenso DBT-app and IT monitoring program | Arm Label: Paperdiary-condition; Type: ACTIVE_COMPARATOR; Interventions: Other: Paper diary sheet | Intervention Type: OTHER; Name: Paper diary sheet; Assigned to Arm(s): Paperdiary-condition | Intervention Type: DEVICE; Name: Monsenso DBT-app and IT monitoring program; Assigned to Arm(s): App-Condition

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Testing the Efficacy of the Teachable Moment Brief Intervention for Suicide Attempt Survivors in an Inpatient Setting: Effects on Psychosocial and Experimental Pain Outcomes
Brief Summary: This study is looking at the helpfulness of a brief treatment targeting suicidality (Teachable Moment Brief Intervention \[TMBI\]) and experimental pain responses in an inpatient population as well as collecting comparison data from the community.


Options:
A: Arm Label: Culturally adapted therapy (C-MAP); Type: EXPERIMENTAL; Interventions: Behavioral: Culturally adapted therapy (C-MAP) | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Culturally adapted therapy (C-MAP); Assigned to Arm(s): Culturally adapted therapy (C-MAP)
B: Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention (TMBI) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Control Group (CCG); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention (TMBI); Assigned to Arm(s): Teachable Moment Brief Intervention
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavioral therapy for adolescents (DBT-A) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Dialectical behavioral therapy for adolescents (DBT-A); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): 2
D: Arm Label: Internet-based ERITA-DK; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA-DK) | Arm Label: Treatment as Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA-DK) | Intervention Type: BEHAVIORAL; Name: Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA-DK); Assigned to Arm(s): Internet-based ERITA-DK, Treatment as Usual (TAU)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Testing the Efficacy of the Teachable Moment Brief Intervention for Suicide Attempt Survivors in an Inpatient Setting: Effects on Psychosocial and Experimental Pain Outcomes
Brief Summary: This study is looking at the helpfulness of a brief treatment targeting suicidality (Teachable Moment Brief Intervention \[TMBI\]) and experimental pain responses in an inpatient population as well as collecting comparison data from the community.


Options:
A: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up
B: Arm Label: Care as Usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention; Assigned to Arm(s): Teachable Moment Brief Intervention
C: Arm Label: Intervention (2Share) + treatment as usual; Type: EXPERIMENTAL; Interventions: Behavioral: 2Share | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: 2Share; Assigned to Arm(s): Intervention (2Share) + treatment as usual
D: Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention (TMBI) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Control Group (CCG); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention (TMBI); Assigned to Arm(s): Teachable Moment Brief Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Modified One-layer Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy After Pancreaticoduodenectomy
Brief Summary: The aim of this study is to compare surgical outcomes of modified One-layer duct-to-mucosa versus invagination pancreaticojejunostomy after pancreatoduodenectomy


Options:
A: Arm Label: Standard drainage; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard drain removal | Arm Label: Short drainage; Type: EXPERIMENTAL; Interventions: Procedure: Drain removal at D4 | Intervention Type: PROCEDURE; Name: Drain removal at D4; Assigned to Arm(s): Short drainage | Intervention Type: PROCEDURE; Name: Standard drain removal; Assigned to Arm(s): Standard drainage
B: Arm Label: No Drains; Type: EXPERIMENTAL; Interventions: Procedure: No Drains | Arm Label: Drains; Type: EXPERIMENTAL; Interventions: Procedure: Drains | Intervention Type: PROCEDURE; Name: No Drains; Assigned to Arm(s): No Drains | Intervention Type: PROCEDURE; Name: Drains; Assigned to Arm(s): Drains
C: Arm Label: Early drain removal; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postoperative drain removal | Arm Label: Standard drain removal; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postoperative drain removal | Intervention Type: PROCEDURE; Name: Postoperative drain removal; Assigned to Arm(s): Early drain removal, Standard drain removal
D: Arm Label: One-layer duct-to-mucosa Group; Type: EXPERIMENTAL; Interventions: Procedure: Modified one-layer duct-to-mucosa Pancreaticojejunostomy | Arm Label: Invagination Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Invagination pancreaticojejunostomy | Intervention Type: PROCEDURE; Name: Modified one-layer duct-to-mucosa Pancreaticojejunostomy; Assigned to Arm(s): One-layer duct-to-mucosa Group | Intervention Type: PROCEDURE; Name: Invagination pancreaticojejunostomy; Assigned to Arm(s): Invagination Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Modified One-layer Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy After Pancreaticoduodenectomy
Brief Summary: The aim of this study is to compare surgical outcomes of modified One-layer duct-to-mucosa versus invagination pancreaticojejunostomy after pancreatoduodenectomy


Options:
A: Arm Label: horizontal mattress; Type: EXPERIMENTAL; Interventions: Procedure: pancreaticojejunostomy with horizontal mattress suture | Arm Label: interrupted suture; Type: EXPERIMENTAL; Interventions: Procedure: pancreaticojejunostomy with interrupted suture | Intervention Type: PROCEDURE; Name: pancreaticojejunostomy with horizontal mattress suture; Assigned to Arm(s): horizontal mattress | Intervention Type: PROCEDURE; Name: pancreaticojejunostomy with interrupted suture; Assigned to Arm(s): interrupted suture
B: Arm Label: one-layer duct-to-mucosa anastomosis; Type: EXPERIMENTAL; Interventions: Procedure: pancreaticojejunostomy | Arm Label: two-layer duct-to-mucosa anastomosis; Type: ACTIVE_COMPARATOR; Interventions: Procedure: pancreaticojejunostomy | Intervention Type: PROCEDURE; Name: pancreaticojejunostomy; Assigned to Arm(s): one-layer duct-to-mucosa anastomosis, two-layer duct-to-mucosa anastomosis
C: Arm Label: Duct to mucosa PJ group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Duct to mucosa PJ group | Arm Label: Invagination PJ group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Invagination PJ group | Intervention Type: PROCEDURE; Name: Duct to mucosa PJ group; Assigned to Arm(s): Duct to mucosa PJ group | Intervention Type: PROCEDURE; Name: Invagination PJ group; Assigned to Arm(s): Invagination PJ group
D: Arm Label: One-layer duct-to-mucosa Group; Type: EXPERIMENTAL; Interventions: Procedure: Modified one-layer duct-to-mucosa Pancreaticojejunostomy | Arm Label: Invagination Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Invagination pancreaticojejunostomy | Intervention Type: PROCEDURE; Name: Modified one-layer duct-to-mucosa Pancreaticojejunostomy; Assigned to Arm(s): One-layer duct-to-mucosa Group | Intervention Type: PROCEDURE; Name: Invagination pancreaticojejunostomy; Assigned to Arm(s): Invagination Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, 2-part, Open-label Study to Evaluate the Safety and Pharmacokinetics of Lumacaftor/Ivacaftor in Subjects 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
Brief Summary: This study will evaluate the safety and pharmacokinetics (PK) of lumacaftor (LUM) and ivacaftor (IVA) in participants 1 to less than 2 years of age with cystic fibrosis (CF), homozygous for F508del (F/F).


Options:
A: Arm Label: ELX/TEZ/IVA; Type: EXPERIMENTAL; Interventions: Drug: ELX/TEZ/IVA, Drug: IVA | Intervention Type: DRUG; Name: ELX/TEZ/IVA; Assigned to Arm(s): ELX/TEZ/IVA | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): ELX/TEZ/IVA
B: Arm Label: Part A: LUM/IVA; Type: EXPERIMENTAL; Interventions: Drug: LUM, Drug: IVA | Arm Label: Part B: LUM/IVA; Type: EXPERIMENTAL; Interventions: Drug: LUM, Drug: IVA | Intervention Type: DRUG; Name: LUM; Assigned to Arm(s): Part A: LUM/IVA, Part B: LUM/IVA | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): Part A: LUM/IVA, Part B: LUM/IVA
C: Arm Label: Ataluren (PTC124®); Type: EXPERIMENTAL; Interventions: Drug: Ataluren (PTC124®) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ataluren (PTC124®); Assigned to Arm(s): Ataluren (PTC124®) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: GLPG2737; Type: EXPERIMENTAL; Interventions: Drug: GLPG2737 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: GLPG2737; Assigned to Arm(s): GLPG2737 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Increasing Safe Outpatient Care for Emergency Department Patients With Acute Pulmonary Embolism: a Pragmatic Trial
Brief Summary: To evaluate the impact of an integrated electronic clinical decision support system to facilitate risk stratification and site-of-care decision-making for patients with acute pulmonary embolism.


Options:
A: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Integration of electronic clinical decision support | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integration of electronic clinical decision support; Assigned to Arm(s): Intervention
B: Intervention Type: PROCEDURE; Name: home treatment; Assigned to Arm(s): N/A
C: Arm Label: Outpatient Treatment; Type: N/A; Interventions: Other: Outpatient Treatment of Pulmonary Embolism | Intervention Type: OTHER; Name: Outpatient Treatment of Pulmonary Embolism; Assigned to Arm(s): Outpatient Treatment
D: Intervention Type: BEHAVIORAL; Name: treatment at home; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Increasing Safe Outpatient Care for Emergency Department Patients With Acute Pulmonary Embolism: a Pragmatic Trial
Brief Summary: To evaluate the impact of an integrated electronic clinical decision support system to facilitate risk stratification and site-of-care decision-making for patients with acute pulmonary embolism.


Options:
A: Intervention Type: PROCEDURE; Name: home treatment; Assigned to Arm(s): N/A
B: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Integration of electronic clinical decision support | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integration of electronic clinical decision support; Assigned to Arm(s): Intervention
C: Arm Label: Outpatient Treatment; Type: N/A; Interventions: Other: Outpatient Treatment of Pulmonary Embolism | Intervention Type: OTHER; Name: Outpatient Treatment of Pulmonary Embolism; Assigned to Arm(s): Outpatient Treatment
D: Arm Label: Outpatient treatment; Type: EXPERIMENTAL; Interventions: Other: Outpatient care (vs traditional inpatient care) | Arm Label: Inpatient care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Outpatient care (vs traditional inpatient care); Assigned to Arm(s): Outpatient treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Protocol For The Randomized Controlled Trial Of Pulsed Short Wave Therapy In Cesarean Section
Brief Summary: This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following Cesarean section. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.


Options:
A: Arm Label: abdominal binder; Type: ACTIVE_COMPARATOR; Interventions: Device: abdominal Binder | Arm Label: No Abdominal Binder; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: abdominal Binder; Assigned to Arm(s): abdominal binder
B: Arm Label: Binder; Type: EXPERIMENTAL; Interventions: Device: Elastic abdominal binder | Arm Label: No binder; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Elastic abdominal binder; Assigned to Arm(s): Binder
C: Arm Label: Active Group; Type: ACTIVE_COMPARATOR; Interventions: Device: RecoveryRx | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Device: Sham RecoveryRx | Intervention Type: DEVICE; Name: RecoveryRx; Assigned to Arm(s): Active Group | Intervention Type: DEVICE; Name: Sham RecoveryRx; Assigned to Arm(s): Control Group
D: Arm Label: Narcotic counseling script; Type: EXPERIMENTAL; Interventions: Behavioral: Narcotic counseling script | Arm Label: Post-partum depression counseling script; Type: SHAM_COMPARATOR; Interventions: Behavioral: Post-partum depression counseling script | Intervention Type: BEHAVIORAL; Name: Narcotic counseling script; Assigned to Arm(s): Narcotic counseling script | Intervention Type: BEHAVIORAL; Name: Post-partum depression counseling script; Assigned to Arm(s): Post-partum depression counseling script

Answer: C